Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hidden diabetes complication under the microscope: charcot foot care revealed

NCT ID NCT03744039

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to learn how Charcot foot, a serious but poorly understood diabetes complication, is currently diagnosed and treated in specialized foot centers across France and Belgium. Researchers collected information from over 1,100 patients to identify common practices and gaps in care. The goal is to use these findings to create better guidelines for managing this condition, which can lead to ulcers and even amputation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,160 people

The number who actually took part.

Started

Jan 2019

Finished

Dec 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

290-1160 consecutive patients with type 1 or type 2 diabetes mellitus and acute or chronic osteo-neuroarthropathy in 29 diabetic-foot centers in France and Belgium (members of workgroup " diabetic foot " in French-speaking Society of Diabetology)

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The patient has received written information about the study and did not oppose to participate * The patient is affiliated to a health insurance programme * The patient is at least 18 years old * The patient is admitted to hospitalization or consultation * The patient is diagnosed with type 1 or type 2 diabetes mellitus * The patient is diagnosed with acute or chronic osteo-neuroarthropathy Exclusion Criteria: * The patient participates in another interventional study * The patient refuses to participate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetic foot neuroarthropathy charcot are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Nîmes - Hôpital Universitaire de Réadaptation du Grau du Roi

    Le Grau-du-Roi, 30240, France

  • Nimes University Hospital

    Nîmes, 30029, France